Publications
5803 Results
- Journal / Conference
- Cancer
- Year
- 2025
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID39932777
- PMC
- PMC11812894
- Study Number(s)
- S1505
Chemotherapy Dose Density is Prognostic for Overall Survival in Patients with Resectable Pancreas Cancer: A Landmark Analysis of SWOG 1505
- Journal / Conference
- NPJ Precision Oncology
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID39856213
- PMC
- PMC11759674
- Study Number(s)
- S1609
Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Metastatic Basal Cell Carcinoma
- Journal / Conference
- European Urology
- Year
- 2025
- Research Committee(s)
- Genitourinary
- PMID
- PMID40404526
- Study Number(s)
- S1605
Urine tumor DNA detection predicts response to atezolizumab in BCG-unresponsive non-muscle-invasive bladder cancer
- Journal / Conference
- Journal of the National Cancer Institute Monographs Mar 1;2025(68):14-21
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery and Melanoma
- PMID
- PMID39989038
- PMC
- PMC11848031
- Study Number(s)
- S1404
Best practices and pragmatic approaches for PRO/QOL measures in cancer clinical trials
- Journal / Conference
- Journal of the National Cancer Institute Monographs Mar 1;2025(68):22-29
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39989043
- PMC
- PMC11848030
Design and Analysis Considerations for Investigating Patient Subgroups of Interest Within Cancer Clinical Trials
- Journal / Conference
- JNCI Cancer Spectr. 2025 Apr 30;9(3):pkaf033. doi: 10.1093/jncics/pkaf033.
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery and Leukemia
- PMID
- PMID40238217
- PMC
- PMC12121638
Guideline-Concordant Treatment among Adolescents and Young Adults (AYAs) with Acute Lymphoblastic Leukemia (ALL)
- Journal / Conference
- Journal for ImmunoTherapy of Cancer
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID40588371
- PMC
- PMC12211841
- Study Number(s)
- S1609
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Pancreatic Neuroendocrine Neoplasm (PNEN) Cohort
- Journal / Conference
- Journal of Clinical Oncology
- Year
- 2025
- Research Committee(s)
- Lymphoma
- PMID
- PMID40523203
- Study Number(s)
- S1826
Nivolumab-AVD versus brentuximab vedotin-AVD in older patients with advanced stage classic Hodgkin lymphoma
- Journal / Conference
- Future Oncol. 2025 May;21(11):1325-1331
- Year
- 2025
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID40155326
- PMC
- PMC12051544
- Study Number(s)
- S2303
S2303: phase II/III trial of paclitaxel + ramucirumab +/- nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
- Journal / Conference
- JCO Oncology Advances
- Year
- 2025
- Research Committee(s)
- Lymphoma
- PMID
- PMID40264918
- PMC
- PMC12011429
- Study Number(s)
- S2308